Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol

Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol

BackgroundIn an observational study in Geneva (Switzerland), we found that administering a standardized THC/CBD oil was feasible, safe, and beneficial in an elderly polymedicated population with severe dementia, behavioral troubles, and pain. Those findings need to be confirmed in a randomized clini...

Full description

Bibliographic Details
Main Authors: Federica Bianchi, Sophie Pautex, James Wampfler, François Curtin, Youssef Daali, Jules Alexandre Desmeules, Barbara Broers
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Pain Research
Subjects:
pain
dementia
behavioural troubles
long-term care facilities
cannabinoids
THC/CBD
Online Access:https://www.frontiersin.org/articles/10.3389/fpain.2023.1108832/full

Internet

https://www.frontiersin.org/articles/10.3389/fpain.2023.1108832/full

Similar Items